These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27171940)

  • 1. The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls.
    Tian X; Wang B; Guo J; Liu X; Zhang T; Liang C; Zhou N; Hou X; Ma Y; Yu H; Chen L; Ren Z; Fan K; Tian Q
    Panminerva Med; 2016 Dec; 58(4):341-348. PubMed ID: 27171940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
    Kong Q; Li P; Tian Q; Ha MW
    Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
    Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
    Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
    Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
    PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
    Yan YL; Han F; Tan WM; Wu CP; Qin X
    Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies.
    Shen W; Hu P; Cao JQ; Liu XX; Shao JH
    J Int Med Res; 2014 Oct; 42(5):1065-76. PubMed ID: 25070969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
    Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
    Xue Z; Zhu X; Teng Y
    Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility.
    Chen B; Xiong MM; Meng XL
    Dis Esophagus; 2015; 28(6):593-601. PubMed ID: 24844868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T309G murine double minute 2 gene polymorphism is an independent prognostic factor for patients with renal cell carcinoma.
    de Martino M; Taus C; Wessely IS; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
    DNA Cell Biol; 2015 Feb; 34(2):107-12. PubMed ID: 25415135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk.
    Song B; Duan ZY; Zhong YH; Lei N; Yang YQ; Luo KY
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6649-51. PubMed ID: 24377582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers.
    Chen B; Cao L; Hu KW; Zhang JW; Meng XL; Xiong MM
    Tumour Biol; 2014 Apr; 35(4):3431-8. PubMed ID: 24338709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.
    Zhuo W; Zhang L; Ling J; Zhu B; Chen Z
    Leuk Lymphoma; 2012 Nov; 53(11):2245-52. PubMed ID: 22563815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between MDM2 T309G single nucleotide polymorphism and esophageal cancer susceptibility: An updated meta-analysis.
    Yin L; Shen G; Zhu B
    Thorac Cancer; 2020 Mar; 11(3):672-678. PubMed ID: 31970867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population.
    Yilmaz M; Tas A; Donmez G; Kacan T; Silig Y
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1059-1062. PubMed ID: 29699057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship Between MDM2 T309G Polymorphism and Leukemia in the Chinese Population: Evidence from a Meta-Analysis.
    Zhao D; Liu T
    Clin Lab; 2017 Oct; 63(10):1639-1645. PubMed ID: 29035454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.
    Chien WP; Wong RH; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2010 Apr; 17(4):1194-202. PubMed ID: 19941079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore.
    Chua HW; Ng D; Choo S; Lum SS; Li H; Soh LY; Sabapathy K; Seow A
    BMC Cancer; 2010 Mar; 10():88. PubMed ID: 20219101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians.
    Gui XH; Qiu LX; Zhang HF; Zhang DP; Zhong WZ; Li J; Xiao YL
    Eur J Cancer; 2009 Jul; 45(11):2023-6. PubMed ID: 19264476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of associations between the MDM2-T309G polymorphism and prostate cancer risk.
    Chen T; Yi SH; Liu XY; Liu ZG
    Asian Pac J Cancer Prev; 2012; 13(9):4327-30. PubMed ID: 23167337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.